30 results
8-K
EX-99.1
BTAX
Biostax Corp.
14 Jan 15
Departure of Directors or Certain Officers
12:00am
brings tremendous operational, M & A, sales and marketing, and financial leadership to the table. The company believes that we can leverage his years … of a variety of companies through economic conditions ranging from boom to bust, developing a rare combination of experience, vision, leadership
8-K
EX-99.1
BTAX
Biostax Corp.
14 Nov 23
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
4:22pm
Secretary of Health and Human Resources under the office of Secretary Jane Woods where he exhibited exceptional leadership in policy coordination … empowerment, Craig Suro continues to shape Virginia’s future. His dynamic approach and visionary leadership make him a driving force behind transformative
8-K
BTAX
Biostax Corp.
5 May 20
Departure of Directors or Certain Officers
5:19pm
was formally accepted on April 30, 2020. Mr. Handley will remain in the leadership of the Company’s non-public affiliates, Cytocom, Inc. and Forte … Board meetings and anticipates this to continue during the current corporate and leadership transition, due to the demands of his pediatric medical
8-K
EX-99.1
BTAX
Biostax Corp.
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
Board of Directors.
“On behalf of the Board and leadership of Immune, I would like to welcome Louis to Immune’s Board,” said Dr. Stephen Wilson, CEO … of Immune. “Mr. Salomonsky’s operational leadership, as well as his track record of deal-making and financial acumen, will be instrumental in moving
8-K
BTAX
Biostax Corp.
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
with the Company’s international leadership, assisting with country management organization and functions. She will work to maximize the potential … of the Company’s growing portfolio of products, many of which are in a combination of approved and growth phases.
Ms. Wilson brings over 25 years of leadership
8-K
EX-99.1
1rgug4n3rz4kfvr9
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
q6b4gy1r
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
60nqja2o6ong hf
14 Sep 23
Biostax Corp Announces the Passing of Esteemed Director, Henry Louis Salomonsky
9:00am
8-K
y4x6b7
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
8-K
ychf69
14 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
5axv0exb219zq3
4 Dec 14
Other Events
12:00am
8-K
EX-99.1
nnvunwkejhmhfxx7vzx
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
10-Q
at1nq50t 1ma8ccat
15 May 13
Quarterly report
12:00am
10-K
ns0w9g21e8hh3s4oy
31 Mar 14
Annual report
12:00am
PRE 14C
kz5hcqwwafdec6b4t
16 Dec 22
Preliminary information
4:31pm